Get access

Antagonist-induced supersensitivity of mGlu1 receptor signalling in cerebellar granule cells

Authors

  • Hilde Lavreysen,

    1. CNS Discovery Research, Johnson and Johnson Pharmaceutical Research and Development, a division of Janssen Pharmaceutica N.V., B-2340 Beerse, Belgium
    2. Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
    Search for more papers by this author
  • Tineke Willemoens,

    1. CNS Discovery Research, Johnson and Johnson Pharmaceutical Research and Development, a division of Janssen Pharmaceutica N.V., B-2340 Beerse, Belgium
    Search for more papers by this author
  • Joseé E. Leysen,

    1. Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
    Search for more papers by this author
  • Anne S. J. Lesage

    1. CNS Discovery Research, Johnson and Johnson Pharmaceutical Research and Development, a division of Janssen Pharmaceutica N.V., B-2340 Beerse, Belgium
    Search for more papers by this author

Dr A. S. J. Lesage, as above.
E-mail: alesage@prdbe.jnj.com

Abstract

We investigated the effect of 24 h sustained treatment with the mGlu1 receptor antagonist CPCCOEt on mGlu1 receptor signalling in primary cultures of rat cerebellar granule cells. In the absence of ionotropic glutamate (iGlu) blockers, the maximal inositol phosphate (IP) response (Emax) but not the potency of glutamate was significantly increased when cells were pre-exposed for 24 h with CPCCOEt. When the contribution of iGlu receptors to the glutamate-induced IP response was eliminated with the use of DNQX, the Emax was again increased but also the concentration eliciting 50% of the maximal glutamate stimulus was significantly decreased. In the absence of iGlu receptor inhibitors, the Emax of quisqualate, which likely mediates IP accumulation only via the mGlu1 receptor, was significantly increased in CPCCOEt-pretreated cells. Also, less quisqualate was needed to reach the same IP effect. The potency of R193845, a selective mGlu1 receptor antagonist, was significantly decreased in antagonist-pretreated cells. These findings demonstrate that 24 h sustained antagonist treatment can render mGlu1 receptors in neurons supersensitive to agonists, with a concomitant decrease in the effectiveness of antagonists.

Get access to the full text of this article

Ancillary